Skip to main content
. 2021 Nov 20;8(12):ofab537. doi: 10.1093/ofid/ofab537

Figure 1.

Figure 1.

Inverse probability of treatment weighted linear and logistic regression estimates of integrase inhibitors on primary and secondary outcomes of interest. INSTI, integrase-strand transfer inhibitor; LDL-C, low-density lipoprotein cholesterol.